Royal Bank of Canada’s Franklin Genomic Advancements ETF HELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-400
Closed -$12K 6513
2024
Q4
$12K Hold
400
﹤0.01% 5797
2024
Q3
$13K Buy
+400
New +$13K ﹤0.01% 5791